BeOne Medicines Ltd.
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302188% above fair value
$355.00−6.27 (-1.74%)
Close on Nov 3, 2026Market cap $40.36BP/E 63.5Yield –
BeOne Medicines Raw Materials Inventory: $267M in Q2 2026, up 47.7% from a year earlier.
Latest, Q2 2026
267
Period ended Jun 30, 2026
Change on a year earlier
+47.7%
181 in Q2 2025
History
26 quarters
Since Q4 2019
Sources
25
Documents cited below
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-05) ↗
Reported in Form 10-Q / 10-K Inventories Note (XBRL).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). BeOne Medicines Raw Materials Inventory ($M), quarterly Q4 2019–Q2 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/inv-raw
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.
See a number that looks wrong?